A next-generation neuroscience CRO partner

Neurological disease preclinical efficacy

From target mechanism and disease models to delivery and multidimensional endpoints, we build preclinical evidence that can be tested, interpreted and advanced.

200+Completed projects
8Integrated platforms
7Neuroscience PhDs
80+High-impact papers
≥80%Model success rate

4C scientific decision

Translate four scientific questions—cause, mechanism, manifestation and treatment choice—into target, model, endpoint and dosing decisions.

PhD-led · Co-designed · Interpreted together
01Why · Target
Causes

Target & mechanism

Define the disease mechanism and translational objective a candidate is designed to address.

Frame the R&D question
02How · Model
Core mechanisms

Best-fit model

Match disease stage, animal background and intervention window.

Build the model strategy
03What · Endpoints
Clinical manifestation

Core endpoints

Combine behavioral, molecular, histology, imaging and electrophysiology readouts.

Build the evidence chain
04Where · Route
Cure choice

Dosing strategy

Design the route, dose frequency and tissue-distribution validation.

Support the next decision

Models & evidence

Explore models, endpoints and representative data by research area.

View all models & evidence

Connect protein pathology and neuronal change with cognitive, motor and efficacy endpoints.

01 / 03

AD · Alzheimer’s disease

Alzheimer's disease

5xFAD: Aβ42 / ThS pathology and quantification across ages and sexes
5xFAD: Aβ42 / ThS pathology and quantification across ages and sexes

Representative models

  • 5xFAD
  • rTg4510
  • APP/PS1
  • P301S

Aβ / Tau pathology, neuroinflammation and cognition.

View model & endpoint details

PD · Parkinson’s disease

Parkinson's disease

MPTP: TH / GFAP staining in Control, MPTP and MPTP + L-DA groups
MPTP: TH / GFAP staining in Control, MPTP and MPTP + L-DA groups

Representative models

  • A53T
  • MPTP
  • PFFs
  • 6-OHDA

α-syn, TH+ neurons and motor-function assessment.

View model & endpoint details

ALS · Amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis

TDP-43: Body-weight and survival curves across groups
TDP-43: Body-weight and survival curves across groups

Representative models

  • SOD1-G93A
  • TDP-43

Motor function, body weight, survival and neuromuscular pathology.

View model & endpoint details
Browse more models horizontallyDiscuss your model needs

Integrated platforms

Eight platforms connect animal care, modeling, dosing and multidimensional analysis for neuroscience studies.

Explore platform capabilities
01

SPF IVC animal care

Animal care

Support disease-model husbandry and health monitoring throughout the study.

SPF IVC housing · Body weight & condition · Age-window tracking
02

Modeling & precision dosing

Modeling & administration

Combine genetic, surgical and stress models with peripheral and CNS routes.

ICV / P0 ICV · IT / IV / SC · Stereotaxic injection
03

Molecular analysis

Molecular analysis

Measure target genes, proteins and related molecular changes across delivery and efficacy endpoints.

qPCR / RT-PCR · Western blot · ELISA
04

Histology & pathology

Histology & pathology

Assess tissue morphology, cellular localization and pathology burden.

Paraffin / frozen / vibratome sections · IHC / IF · RNAscope
05

Behavioral phenotyping

Behavioral phenotyping

Cover cognition, motor function, sociability, emotion and sensory pain across 12 behavioral domains.

Morris water maze / Y-maze · Three-chamber social · Rotarod / grip / beam walk
06

Microscopy & live imaging

Microscopy & imaging

Visualize brain regions, tissue and whole-body distribution with microscopy and live imaging.

Fluorescence microscopy · Optical imaging · MRI / CT
07

Electrophysiology & physiology

Electrophysiology & physiology

Connect neuronal activity, synaptic function and systemic physiology.

Action potential / membrane potential · mEPSC / mIPSC · LTP / LTD / fEPSPs
08

Nucleic acid delivery screening

Nucleic acid screening

Compare candidates, routes and target-tissue effects to support delivery selection.

siRNA / ASO / mRNA · Peripheral and CNS dosing · Multi-tissue quantification
13Dosing routes
50+Tissue types
10Molecular assays
9Imaging methods
11Electrophysiology & physiology
12Behavioral domains

Collaboration network

We work with universities, hospitals and biopharma teams to support study validation, pipeline progress and translation.

50+

Universities & research institutes

20+

Hospitals

80+

Industry & specialist organisations

How we work

Bring a target, candidate or development question. We turn it into an executable model, endpoint and data-delivery plan.

01Deep consultationAlign target, mechanism and development stage
02Study designConfirm model, endpoints, route and scope
03Expert executionPhD oversight, SOPs and process records
04Data deliveryInterpretation and next-step recommendations

Technical contact

Discuss your target, model or delivery question and learn about study plans, project scope and pricing.